The Light Peak of the Electroretinogram Is Dependent on Voltage-gated Calcium Channels and Antagonized by Bestrophin (Best-1)

Journal of General Physiology - Tập 127 Số 5 - Trang 577-589 - 2006
Lihua Y. Marmorstein1, Jiang Wu2, P. J. McLaughlin1, John Yocom1, Michael Karl3, Rudgar Neussert3, Soenke Wimmers3, J. Brett Stanton1, Ronald G. Gregg4, Olaf Strauß3, Neal S. Peachey2,5, Alan D. Marmorstein1,6
11Department of Ophthalmology and Vision Science
23Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH 44195
34Experimentelle Ophthalmologie Universitaetsklinkum Hamburg-Eppendorf, Hamburg, Germany
45Biochemistry and Molecular Biology, Ophthalmology and Visual Science, University of Louisville, KY 40202
56Research Service, Cleveland VA Medical Center, Cleveland, OH 44106
62Optical Sciences Center, University of Arizona, Tucson, AZ 85711

Tóm tắt

Mutations in VMD2, encoding bestrophin (best-1), cause Best vitelliform macular dystrophy (BMD), adult-onset vitelliform macular dystrophy (AVMD), and autosomal dominant vitreoretinochoroidopathy (ADVIRC). BMD is distinguished from AVMD by a diminished electrooculogram light peak (LP) in the absence of changes in the flash electroretinogram. Although the LP is thought to be generated by best-1, we find enhanced LP luminance responsiveness with normal amplitude in Vmd2−/− mice and no differences in cellular Cl− currents in comparison to Vmd2+/+ littermates. The putative Ca2+ sensitivity of best-1, and our recent observation that best-1 alters the kinetics of voltage-dependent Ca2+ channels (VDCC), led us to examine the role of VDCCs in the LP. Nimodipine diminished the LP, leading us to survey VDCC β-subunit mutant mice. Lethargic mice, which harbor a loss of function mutation in the β4 subunit of VDCCs, exhibited a significant shift in LP luminance response, establishing a role for Ca2+ in LP generation. When stimulated with ATP, which increases [Ca++]I, retinal pigment epithelial cells derived from Vmd2−/− mice exhibited a fivefold greater response than Vmd2+/+ littermates, indicating that best-1 can suppress the rise in [Ca2+]I associated with the LP. We conclude that VDCCs regulated by a β4 subunit are required to generate the LP and that best-1 antagonizes the LP luminance response potentially via its ability to modulate VDCC function. Furthermore, we suggest that the loss of vision associated with BMD is not caused by the same pathologic process as the diminished LP, but rather is caused by as yet unidentified effects of best-1 on other cellular processes.

Từ khóa


Tài liệu tham khảo

1999, Hum. Genet., 104, 449, 10.1007/s004390050986

2003, Invest. Ophthalmol. Vis. Sci., 44, 3622, 10.1167/iovs.03-0030

2002, Invest. Ophthalmol. Vis. Sci., 43, 1595

1984, Br. J. Ophthalmol., 68, 2, 10.1136/bjo.68.1.2

2001, EMBO J., 20, 1289, 10.1093/emboj/20.6.1289

1997, Cell., 88, 385, 10.1016/S0092-8674(00)81877-2

1999, Mol. Cell. Neurosci., 13, 293, 10.1006/mcne.1999.0748

1974, Am. J. Ophthalmol., 77, 46, 10.1016/0002-9394(74)90603-5

1969, Br. J. Ophthalmol., 81, 305

2000, Am. J. Hum. Genet., 66, 1531, 10.1086/302909

2005, J. Physiol., 562, 477, 10.1113/jphysiol.2004.075622

1982, Arch. Ophthalmol., 100, 1115, 10.1001/archopht.1982.01030040093017

1998

1989, J. Neurosci., 9, 1977, 10.1523/JNEUROSCI.09-06-01977.1989

1997

1986, Acta Ophthalmol. Suppl., 175, 1

1996, Proc. Natl. Acad. Sci. USA., 93, 13961, 10.1073/pnas.93.24.13961

1984, J. Gen. Physiol., 83, 193, 10.1085/jgp.83.2.193

1985, J. Biol. Chem., 260, 3440, 10.1016/S0021-9258(19)83641-4

1992, Arch. Ophthalmol., 110, 1563, 10.1001/archopht.1992.01080230063021

2005, Annu. Rev. Physiol., 67, 719, 10.1146/annurev.physiol.67.032003.154341

2000, J. Neurosci., 20, 5733, 10.1523/JNEUROSCI.20-15-05733.2000

2000, Eur. J. Hum. Genet., 8, 286, 10.1038/sj.ejhg.5200447

1983, J. Neurophysiol., 50, 136, 10.1152/jn.1983.50.1.136

1984, J. Gen. Physiol., 83, 213, 10.1085/jgp.83.2.213

1979, Ann. Ophthalmol., 11, 1705

2000, Proc. Natl. Acad. Sci. USA., 97, 12758, 10.1073/pnas.220402097

2004, Invest. Ophthalmol. Vis. Sci., 45, 3733, 10.1167/iovs.04-0307

1998, Hum. Mol. Genet., 7, 1517, 10.1093/hmg/7.9.1517

2002, Exp. Eye Res., 74, 29, 10.1006/exer.2001.1128

2001, J. Physiol., 534, 193, 10.1111/j.1469-7793.2001.00193.x

2005, Arch. Ophthalmol., 123, 1588, 10.1001/archopht.123.11.1588

1988, Arch. Ophthalmol., 106, 1261, 10.1001/archopht.1988.01060140421045

2002, Vis. Neurosci., 19, 693, 10.1017/S0952523802196015

1997, J. Neurosci., 17, 2324, 10.1523/JNEUROSCI.17-07-02324.1997

1998, Nat. Genet., 19, 241, 10.1038/915

2001, J. Cell Sci., 114, 2223, 10.1242/jcs.114.12.2223

2004, J. Gen. Physiol., 124, 371, 10.1085/jgp.200409108

2003, J. Biol. Chem., 278, 49563, 10.1074/jbc.M308414200

2004, J. Gen. Physiol., 123, 327, 10.1085/jgp.200409031

2005, Am. J. Physiol. Cell Physiol., 288, C132, 10.1152/ajpcell.00201.2004

1995, Vis. Neurosci., 12, 837, 10.1017/S0952523800009408

1998, Doc. Ophthalmol., 95, 187, 10.1023/A:1001891904176

2003, J. Physiol., 547, 509, 10.1113/jphysiol.2002.030304

2006, FASEB J., 20, 178, 10.1096/fj.05-4495fje

2001, Ophthalmology., 108, 2060, 10.1016/S0161-6420(01)00777-1

2006, Biochim. Biophys. Acta.

1985

2002, Proc. Natl. Acad. Sci. USA., 99, 4008, 10.1073/pnas.052692999

2003, J. Biol. Chem., 278, 41114, 10.1074/jbc.M306150200

1994, Exp. Eye Res., 58, 331, 10.1006/exer.1994.1023

1982, Arch. Ophthalmol., 100, 1108, 10.1001/archopht.1982.01030040086016

1996, Proc. Natl. Acad. Sci. USA., 93, 1167, 10.1073/pnas.93.3.1167

2000, Hum. Mutat., 15, 301, 10.1002/(SICI)1098-1004(200004)15:4<301::AID-HUMU1>3.0.CO;2-N

2004, Mol. Vis., 10, 650

2004, J. Neurophysiol., 91, 1134, 10.1152/jn.00958.2003

2006, Exp. Eye Res.

2004, Invest. Ophthalmol. Vis. Sci., 45, 3683, 10.1167/iovs.04-0550

1994, Science., 266, 1705, 10.1126/science.7527588